ImmunityBio (IBRX) Free Cash Flow (2014 - 2026)
ImmunityBio (IBRX) reported Free Cash Flow of -$77.2 million for Q1 2026, up 10.16% year-over-year from -$70.1 million in Q1 2025, and down 8.27% on a QoQ basis from -$71.3 million in Q4 2025.
ImmunityBio (IBRX) has 13 years of Free Cash Flow data on file, last reported at -$77.2 million in Q1 2026.
- Quarterly Free Cash Flow rose 10.16% year-over-year to -$77.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$300.1 million (up 18.66% YoY) and the FY2025 annual result came in at -$308.8 million, up 21.08% from the prior year.
- Free Cash Flow retreated to -$77.2 million in Q1 2026 per IBRX's latest filing, from -$71.3 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$70.5 million in Q3 2025 and bottomed at -$123.2 million in Q4 2023.
- The 5-year median for Free Cash Flow is -$85.9 million (2025), against an average of -$89.7 million.
- The widest annual swing landed in 2022, when Free Cash Flow plunged 51.25%; it then soared 34.78% in 2024.
- Tracing IBRX's Free Cash Flow over 5 years: stood at -$91.0 million in 2022, then slumped by 35.49% to -$123.2 million in 2023, then soared by 34.78% to -$80.4 million in 2024, then rose by 11.31% to -$71.3 million in 2025, then declined by 8.27% to -$77.2 million in 2026.
- Per Business Quant, the three latest IBRX Free Cash Flow figures stand at -$77.2 million (Q1 2026), -$71.3 million (Q4 2025), and -$70.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 48.67 Mn |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn | -77.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -77.18 Mn |
| Mar 31, 2026 | -77.18 Mn |
| Dec 31, 2025 | -71.28 Mn |
| Dec 31, 2025 | -71.28 Mn |
| Sep 30, 2025 | -70.50 Mn |
| Sep 30, 2025 | -70.50 Mn |
| Jun 30, 2025 | -81.10 Mn |
| Jun 30, 2025 | -81.10 Mn |
| Mar 31, 2025 | -85.91 Mn |
| Mar 31, 2025 | -85.91 Mn |
| Dec 31, 2024 | -80.37 Mn |
| Dec 31, 2024 | -80.37 Mn |
| Sep 30, 2024 | -101.56 Mn |
| Sep 30, 2024 | -101.56 Mn |
| Jun 30, 2024 | -101.07 Mn |
| Jun 30, 2024 | -101.07 Mn |
| Mar 31, 2024 | -108.24 Mn |
| Mar 31, 2024 | -108.24 Mn |
| Dec 31, 2023 | -123.23 Mn |
| Dec 31, 2023 | -123.23 Mn |
| Sep 30, 2023 | -98.04 Mn |
| Sep 30, 2023 | -98.04 Mn |
| Jun 30, 2023 | -72.73 Mn |
| Jun 30, 2023 | -72.73 Mn |
| Mar 31, 2023 | -103.34 Mn |
| Mar 31, 2023 | -103.34 Mn |
| Dec 31, 2022 | -90.95 Mn |
| Dec 31, 2022 | -90.95 Mn |
| Sep 30, 2022 | -79.62 Mn |
| Sep 30, 2022 | -79.62 Mn |
| Jun 30, 2022 | -103.65 Mn |
| Jun 30, 2022 | -103.65 Mn |
| Mar 31, 2022 | -75.99 Mn |
| Mar 31, 2022 | -75.99 Mn |
| Dec 31, 2021 | -60.13 Mn |
| Dec 31, 2021 | -60.13 Mn |
| Sep 30, 2021 | -87.53 Mn |
| Sep 30, 2021 | -87.53 Mn |
| Jun 30, 2021 | -73.68 Mn |
| Jun 30, 2021 | -73.68 Mn |
| Mar 31, 2021 | -64.74 Mn |
| Mar 31, 2021 | -64.74 Mn |
| Dec 31, 2020 | -56.91 Mn |
| Dec 31, 2020 | -56.91 Mn |
| Sep 30, 2020 | -36.99 Mn |
| Sep 30, 2020 | -36.99 Mn |
| Jun 30, 2020 | -48.02 Mn |
| Jun 30, 2020 | -48.02 Mn |
| Mar 31, 2020 | -31.47 Mn |
| Mar 31, 2020 | -31.47 Mn |
| Dec 31, 2019 | -106.42 Mn |
| Dec 31, 2019 | -106.42 Mn |
| Sep 30, 2019 | -18.77 Mn |
| Sep 30, 2019 | -18.77 Mn |
| Jun 30, 2019 | -16.10 Mn |
| Jun 30, 2019 | -16.10 Mn |
| Mar 31, 2019 | -15.11 Mn |
| Mar 31, 2019 | -15.11 Mn |
| Dec 31, 2018 | -7.64 Mn |
| Dec 31, 2018 | -7.64 Mn |
| Sep 30, 2018 | -21.23 Mn |
| Sep 30, 2018 | -21.23 Mn |
| Jun 30, 2018 | -18.76 Mn |
| Jun 30, 2018 | -18.76 Mn |
| Mar 31, 2018 | -20.41 Mn |
| Mar 31, 2018 | -20.41 Mn |
| Dec 31, 2017 | 242,000.00 |
| Dec 31, 2017 | 242,000.00 |
| Sep 30, 2017 | -20.85 Mn |
| Sep 30, 2017 | -20.85 Mn |
| Jun 30, 2017 | -23.11 Mn |
| Jun 30, 2017 | -23.11 Mn |
| Mar 31, 2017 | -14.57 Mn |
| Mar 31, 2017 | -14.57 Mn |
| Dec 31, 2016 | -12.11 Mn |
| Dec 31, 2016 | -12.11 Mn |
| Sep 30, 2016 | -13.76 Mn |
| Sep 30, 2016 | -13.76 Mn |
| Jun 30, 2016 | -9.36 Mn |
| Jun 30, 2016 | -9.36 Mn |
| Mar 31, 2016 | -9.92 Mn |
| Mar 31, 2016 | -9.92 Mn |
| Dec 31, 2015 | -11.90 Mn |
| Dec 31, 2015 | -11.90 Mn |
| Sep 30, 2015 | -5.33 Mn |
| Sep 30, 2015 | -5.33 Mn |
| Jun 30, 2015 | -2.90 Mn |
| Jun 30, 2015 | -2.90 Mn |
| Mar 31, 2015 | -7.41 Mn |
| Mar 31, 2015 | -7.41 Mn |
| Dec 31, 2014 | -2.61 Mn |
| Dec 31, 2014 | -2.61 Mn |
| Sep 30, 2014 | -934,000.00 |
| Sep 30, 2014 | -934,000.00 |
| Jun 30, 2014 | -2.05 Mn |
| Jun 30, 2014 | -2.05 Mn |
| Mar 31, 2014 | -38,000.00 |
| Mar 31, 2014 | -38,000.00 |